How Ph.D. was paid
$13.4M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Kyle W. Gano, Ph.D.Chief Executive Officer | $920,000 | $966,000 | $5,750,023 | $5,750,006 | $62,906 | $13,448,935 |
| Matthew C. AbernethyChief Financial Officer | $725,913 | $526,000 | $2,499,918 | $2,500,036 | $60,045 | $6,311,912 |
| Eric BenevichChief Commercial Officer | $668,690 | $463,000 | $2,349,928 | $2,349,995 | $57,334 | $5,888,947 |
| Sanjay Keswani, M.D.Chief Medical Officer | $379,167 | $488,000 | $4,000,120 | $3,999,963 | $140,553 | $9,007,803 |
| Jude Onyia, Ph.D.Chief Scientific Officer | $720,520 | $645,000 | $2,999,925 | $3,000,011 | $45,313 | $7,410,769 |
| Eiry W. Roberts, M.D.Strategic Advisor | $731,400 | $530,000 | $2,375,004 | $2,375,029 | $61,599 | $6,073,032 |
What changed and why
- $13.4MCEO total compensation increased to $13,448,935 in fiscal 2025 following promotion and performance adjustments.
- $9MDr. Sanjay Keswani joined as Chief Medical Officer in June 2025 with an initial total compensation of $9,007,803.
- Executive compensation program relies heavily on long-term equity incentives including stock options, RSUs, and PRSUs.
- Amended and restated employment agreements were implemented for executive officers in February 2025 to align with the Executive Severance Plan.
- 99%Stockholders previously approved the executive compensation program with approximately 99% support at the 2023 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.